A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
http://t.co/aj6xSaH4e3 Un video de @NEJM explicando IMPROVE-IT http://t.co/Z0Q3rmrSkH
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Main results of IMPROVE-IT have finally been published in NEJM. http://t.co/Y3BhlWNNI7 Nothing terribly new or exciting.
Habemus IMPROVE-IT en @NEJM http://t.co/vVitbFtDtV @secardiologia Ya tardaba la publicacion... http://t.co/gGhSKDEctP
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Main results of IMPROVE-IT have finally been published in NEJM. http://t.co/Y3BhlWNNI7 Nothing terribly new or exciting.
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE IT Simvastatina 40 mas ezitimibe 10 vs simvastatina 40 mas placebo en SCA. http://t.co/VwfmuUlQSt
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Main results of IMPROVE-IT have finally been published in NEJM. http://t.co/Y3BhlWNNI7 Nothing terribly new or exciting.
Main results of IMPROVE-IT have finally been published in NEJM. http://t.co/Y3BhlWNNI7 Nothing terribly new or exciting.
Main results of IMPROVE-IT have finally been published in NEJM. http://t.co/Y3BhlWNNI7 Nothing terribly new or exciting.
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Habemus IMPROVE-IT en @NEJM http://t.co/vVitbFtDtV @secardiologia Ya tardaba la publicacion... http://t.co/gGhSKDEctP
$MRK IMPROVE-IT Data finally published in NEJM 6mo after AHA http://t.co/okxyCGZs86 Editorial http://t.co/19Psz1DlEr http://t.co/a1WvKhBvfQ
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE IT Simvastatina 40 mas ezitimibe 10 vs simvastatina 40 mas placebo en SCA. http://t.co/VwfmuUlQSt
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
Habemus IMPROVE-IT en @NEJM http://t.co/vVitbFtDtV @secardiologia Ya tardaba la publicacion... http://t.co/gGhSKDEctP
http://t.co/aj6xSaH4e3 Un video de @NEJM explicando IMPROVE-IT http://t.co/Z0Q3rmrSkH
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
IMPROVE-IT: Ezetimibe provided incremental LDL lowering when added to statin therapy and improved CV outcomes. http://t.co/CJtqs0KINB
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
Habemus IMPROVE-IT en @NEJM http://t.co/vVitbFtDtV @secardiologia Ya tardaba la publicacion... http://t.co/gGhSKDEctP
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9
Nu är den banne mig här. @NEJM-publikationen av Improve-it om värdet av extra kolesterolsänkning. http://t.co/85Evg64xfB Ping @EvidensJonas
A non-statin (ezetimibe) reduces heart disease risk a bit (in 2/100 people) & supports low LDL http://t.co/0fDIKox0zi http://t.co/hDkC8kYlR9